These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4025540)

  • 1. Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat.
    Krarup T; Holst JJ; Larsen KL
    Am J Physiol; 1985 Aug; 249(2 Pt 1):E195-200. PubMed ID: 4025540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ; Miller LJ; Service FJ; Go VL
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting and postprandial plasma GIP values in man measured with seven different antisera.
    Jorde R; Burhol PG; Schulz TB
    Regul Pept; 1983 Sep; 7(1):87-94. PubMed ID: 6647890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preceding hyperinsulinemia prevents demonstration of insulin effect on fat-induced gastric inhibitory polypeptide (GIP).
    Stöckmann F; Ebert R; Creutzfeldt W
    Diabetes; 1984 Jun; 33(6):580-5. PubMed ID: 6373462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of gastric inhibitory polypeptide (GIP) and the effect of intraduodenal acidification on glucose-stimulated and unstimulated GIP release in humans.
    Flaten O
    Scand J Gastroenterol; 1981; 16(4):545-54. PubMed ID: 7034154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.
    Schattenmann G; Ebert R; Siewert R; Creutzfeldt W
    Scand J Gastroenterol; 1984 Mar; 19(2):260-6. PubMed ID: 6372074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar plasma GIP responses in obese and lean subjects after an oral test meal and after intraduodenal stimulation with fat and glucose.
    Amland PF; Jorde R; Burhol PG; Giercksky KE
    Int J Obes; 1984; 8(6):649-53. PubMed ID: 6398318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man.
    Lucey MR; Fairclough PD; Wass JA; Kwasowski P; Medbak S; Webb J; Rees LH
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):209-17. PubMed ID: 6148162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting and postprandial GIP values in pigs, rats, dogs, and man measured with five different GIP antisera.
    Amland PF; Jorde R; Revhaug A; Myhre ES; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1984 Nov; 19(8):1095-8. PubMed ID: 6533778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of truncal vagotomy on GIP release induced by intraduodenal glucose or fat in dogs.
    Yoshiya K; Yamamura T; Ishikawa Y; Utsunomiya J; Takemura J; Takeda J; Seino Y; Imura H
    Digestion; 1985; 31(1):41-6. PubMed ID: 3979679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of plasma gastric inhibitory polypeptide (GIP), release of GIP after a test meal and duodenal infusion of bile, and immunoreactive plasma GIP components in man.
    Burhol PG; Jorde R; Waldum HL
    Digestion; 1980; 20(5):336-45. PubMed ID: 7390059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera.
    Krarup T; Holst JJ
    Regul Pept; 1984 Sep; 9(1-2):35-46. PubMed ID: 6505290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of gastric secretion by fat and hypertonic glucose in the dog: role of gastric inhibitory peptide.
    Creutzfeldt W; Ebert R; Finke U; Konturek SJ; Kwiecień N; Radecki T
    J Physiol; 1983 Jan; 334():91-101. PubMed ID: 6864570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice.
    Flatt PR; Bailey CJ; Kwasowski P; Page T; Marks V
    J Endocrinol; 1984 Jun; 101(3):249-56. PubMed ID: 6374002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of gastric inhibitory polypeptide and insulin secretion.
    Williams RH; May JM; Biesbroeck JB
    Metabolism; 1981 Jan; 30(1):36-40. PubMed ID: 7007799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabetics.
    Krarup T; Holst JJ; Madsbad S
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):74-83. PubMed ID: 3544634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats.
    Ebert R; Illmer K; Creutzfeldt W
    Gastroenterology; 1979 Mar; 76(3):515-23. PubMed ID: 34554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-induced release of immunoreactive gastric inhibitory polypeptide (IR-GIP) into the duodenal lumen in man.
    Jorde R; Burhol PG; Schulz TB
    Scand J Gastroenterol; 1981; 16(5):653-6. PubMed ID: 7323698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gastric inhibitory polypeptide (GIP) (author's transl].
    Ebert R; Finke U
    Z Gastroenterol; 1978 May; 16(5):311-6. PubMed ID: 654387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radioimmunoassay of gastric inhibitory polypeptide in human plasma.
    Sarson DL; Bryant MG; Bloom SR
    J Endocrinol; 1980 Jun; 85(3):487-96. PubMed ID: 7411011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.